The study on the relationship between renin activity and hypotensive efficacy of uncombined angiotensin II receptor blockers(ARB) therapy and combined ARB+diuretic therapy for hypertension.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Telmisartan (Primary) ; Hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 17 Dec 2011 Status changed from recruiting to suspended as reported by University Hospital Medical Information Network-Japan.
- 11 Apr 2011 New trial record